Safety profile of robotic-assisted transperineal MRI-US-fusion guided biopsy of the prostate.

ABSTRACT:

Introduction

Robotic-assisted transperineal MRI-US-fusion guided biopsy of the prostate is a novel and highly accurate procedure. The aim of this study was to evaluate the MonaLisa prostate biopsy system in terms of safety, tolerability, and patient-related outcomes.

Methods

This prospective study included 228 patients, who had undergone Robotic-assisted transperineal MRI-US-fusion guided biopsy of the prostate at the University Hospital Basel between January 2020 and June 2022. Peri-operative side effects, functional outcomes and patient satisfaction were assessed.

Results

Mean pain score on the day of biopsy was 1.3 points on VAS, which remained constant on the day after biopsy. Overall, 32 of 228 patients (14%) developed grade I complications according to Clavien-D

SUBMITTER: Walter M 

PROVIDER: S-EPMC9751759 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature